Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P50502 (
Hip
)
7,003
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We analyzed the clinical, biological, and radiological aspects of hip involvement in juvenile idiopathic arthritis (JIA) in a developing country. The recruited patients fulfilled the International League Against Rheumatism criteria for the diagnosis of the JIA. Clinical, biological, and radiological parameters relating to the JIA were collected.
Hip
involvement was assessed according to clinical and radiological data related to hip disease. One hundred twenty-one patients were included (68 girls and 53 boys). The mean age of the disease onset was 9 +/- 4.2 years (1-16 years). The mean age of the patients at the time of the study was 15 +/- 10 years (2-46 years). The duration of the disease was 5 +/- 8.5 years (0.5-39 years). Forty cases (33%) of the hip involvement were noted. The mean age was 24 +/- 10.03 years (3-46 years); the sex ratio was 1:3. The mean duration of the hip disease was 0.6 +/- 3.6 years (3-14 years).
Hip
arthritis seemed to be more frequent in polyarticular and enthesitis-related arthritis. The severity of the hip involvement was significantly correlated with
early disease onset
, disease duration, subtypes, and high disability (for all these data p < 0.05). This study suggested that in JIA hip involvement was more frequent in enthesitis-related arthritis and polyarticular subtypes. It was correlated with the severity and the
early disease onset
of the JIA, which was similar to reported data.
...
PMID:Hip involvement in juvenile idiopathic arthritis. 1827 12